CC

CDG Capital

Africa, Rabat-Sale-Zemmour-Zaer, Morocco, Rabat

Description

CDG Capital is a boutique investment banking firm.

Investor Profile

CDG Capital has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C rounds (top funding stages).
  • Majority of deals are located in China, Singapore.
  • Strong thematic focus on Biotechnology, Life Science, Pharmaceutical.

Stage Focus

  • Series B (50%)
  • Series C (50%)

Country Focus

  • China (50%)
  • Singapore (50%)

Industry Focus

  • Biotechnology
  • Life Science
  • Pharmaceutical
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CDG Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Ascendis Pharma
North America, California, United States, Palo Alto
Co-Investments: 1
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 1
PB
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Sherpa Healthcare Partners
Asia, Beijing, China, Beijing
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by CDG Capital?

Mirxes

Singapore, Central Region, Singapore

Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.

BiotechnologyHealth CareLife Science
Series CFeb 22, 2022
Amount Raised: $87,000,000
Visen Pharmaceuticals

Shanghai, Shanghai, China

Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.

BiotechnologyLife SciencePharmaceutical
Series BJan 8, 2021
Amount Raised: $150,000,000